Chittaranjan Andrade, MD
Dr Andrade is Adjunct Professor, Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India, and Senior Professor (Retd), Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India
Clinical and Practical Psychopharmacology
Diabetic medications and major congenital malformations
March 11, 2024
Diabetes is prevalent and poses risks to both mother and child during pregnancy. Evidence shows that diabetes is best treated during pregnancy, with insulin a first-line treatment and metformin...
Clinical and Practical Psychopharmacology
Physical Exercise and Health, 5: Sedentary Time as a Risk Factor for Adverse Physical and Mental Health Outcomes
January 29, 2024
Topics include why sedentariness is important, how it is defined and assessed, and why sedentary behaviors are common in daily life.
Clinical and Practical Psychopharmacology
Physical Exercise and Health, 4: A Guide to Understanding What to Do, How, and Why—Part 2
December 11, 2023
Subjects covered include how cardiorespiratory, muscle-strengthening, balancing, and other exercises benefit the heart, strengthen muscles and bones, improve balance, and reduce risk of falls and fractures. Guidance is provided...
Clinical and Practical Psychopharmacology
Physical Exercise and Health, 2: Benefits of Different Levels and Patterns of Activity
October 11, 2023
This article provides guidance about exercise for adults, including how many steps per day are enough, whether bursts of activity during the day improve health, and whether “weekend warrior”...
Clinical and Practical Psychopharmacology
Using Percentiles to Understand Standardized Mean Difference as a Measure of Effect Size
August 7, 2023
Chittaranjan Andrade, MD, explains the use of SMDs as a measure of effect size. A recent meta-analysis of the effect of ChEIs on hallucinations and delusions in Alzheimer and...
Clinical and Practical Psychopharmacology
ChEIs for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Significant Benefits?
July 31, 2023
Chittaranjan Andrade, MD, takes a closer look at a recent meta-analysis indicating that donepezil, rivastigmine, and galantamine lessened both delusions and hallucinations in Alzheimer disease and Parkinson disease.
